Abiopharma

Director FISHER MARY 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000700

Director Bradrick Brittany 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000694

Director Zanganeh Mahkam 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

LO FRANCIS 🟡 adjusted position in 3.1K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $16.08 Transaction Date: Jan 02, 2026 | Filing ID: 000001

Director DUGGAN ROBERT W 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Summit Plc - Statement of changes in beneficial ownership of securities

New Form SCHEDULE 13D/A - Anixa Biosciences Inc Filed: 2026-01-06 AccNo: 0001493152-26-000691 Size: 6 KB

Rosenberg Ellen 🔴 sold 43.1K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005049

Director KOZARICH JOHN W 🔴 sold 467 shares of LIGAND PHARMACEUTICALS INC (LGND) at $192.40 Transaction Date: Jan 02, 2026 | Filing ID: 000004

Castelli Jeff 🔴 sold 30.0K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005047

Prout Samantha 🔴 sold 15.7K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005045

Clark David Michael 🔴 sold 23.9K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005043

Director SELICK HAROLD E 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001479

Director Titterton Lewis H jr 🟢 acquired 25.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 Transaction Date: Jan 05, 2026 | Filing ID: 000689

Director Waddill William D. 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001478